Proteomics

Dataset Information

0

Signaling Mechanisms in Initiation of Lithium-Induced Nephrogenic Diabetes Insipidus


ABSTRACT: Lithium treatment is commonly used to treat bipolar disorder. However, this treatment disrupts kidney fuctionality. We used microdissected cortical collecting ducts to study proteomics and ultimately discover what changes occur in protein expression after 72-hr lithium treatment.

INSTRUMENT(S): Orbitrap Fusion Lumos

ORGANISM(S): Rattus Norvegicus (rat)

TISSUE(S): Epithelial Cell, Kidney

DISEASE(S): Nephrogenic Diabetes Insipidus

SUBMITTER: Gabirelle Gilmer  

LAB HEAD: Mark Knepper

PROVIDER: PXD010118 | Pride | 2019-07-01

REPOSITORIES: Pride

altmetric image

Publications

RNA-Seq and protein mass spectrometry in microdissected kidney tubules reveal signaling processes initiating lithium-induced nephrogenic diabetes insipidus.

Sung Chih-Chien CC   Chen Lihe L   Limbutara Kavee K   Jung Hyun Jun HJ   Gilmer Gabrielle G GG   Yang Chin-Rang CR   Lin Shih-Hua SH   Khositseth Sookkasem S   Chou Chung-Lin CL   Knepper Mark A MA  

Kidney international 20190304 2


Lithium salts, used for treating bipolar disorder, frequently induce nephrogenic diabetes insipidus (NDI) thereby limiting therapeutic success. NDI is associated with loss of expression of the gene coding for the molecular water channel, aquaporin-2, in the renal collecting duct (CD). Here, we use systems biology methods in a well-established rat model of lithium-induced NDI to identify signaling pathways activated at the onset of polyuria. Using single-tubule RNA-Seq, full transcriptomes were d  ...[more]

Similar Datasets

2017-06-10 | GSE69779 | GEO
2022-04-04 | PXD018791 | Pride
2012-08-24 | E-GEOD-32363 | biostudies-arrayexpress
2012-08-24 | GSE32363 | GEO
2022-07-20 | GSE200928 | GEO
2009-10-30 | E-GEOD-17739 | biostudies-arrayexpress
2017-02-27 | GSE68389 | GEO
2020-12-21 | PXD018795 | Pride
2023-11-30 | GSE215875 | GEO
| PRJNA147689 | ENA